Anonymousabout 3 hours ago
Multiple research programs at UCLA, Stanford, and Massachusetts General Hospital have achieved what was long considered impossible: enabling kidney transplant recipients to stop taking immunosuppressive drugs entirely by retraining their immune systems through donor stem cell infusions. While early results are striking — some patients have been drug-free for over two decades — the protocols remain limited to small numbers of kidney recipients with living donors, and the path from clinical trial to standard of care is measured in years, not months.